These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38940257)

  • 1. Current understanding of Duchenne muscular dystrophy - a purported interview with a purported expert.
    Meyer-Szary J; Mikulski S
    Cardiol J; 2024; 31(3):367-368. PubMed ID: 38940257
    [No Abstract]   [Full Text] [Related]  

  • 2. Duchenne and Becker muscular dystrophies.
    Flanigan KM
    Neurol Clin; 2014 Aug; 32(3):671-88, viii. PubMed ID: 25037084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and management of Duchenne muscular dystrophy.
    Baxter P
    Dev Med Child Neurol; 2010 Apr; 52(4):313. PubMed ID: 20412247
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiomyopathy of Duchenne muscular dystrophy: current understanding and future directions.
    Spurney CF
    Muscle Nerve; 2011 Jul; 44(1):8-19. PubMed ID: 21674516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approaching therapies for boys with Duchenne muscular dystrophy. Parent Project Muscular Dystrophy. Annual conference in Cincinnati/Ohio, 13-16 July 2006.
    Scheuerbrandt G
    Acta Myol; 2006 Oct; 25(2):77-97. PubMed ID: 18593009
    [No Abstract]   [Full Text] [Related]  

  • 6. Outcome measures in Duchenne muscular dystrophy: are we ready for the new therapeutic era?
    Merkies IS; Faber CG
    Neuromuscul Disord; 2009 Jun; 19(6):447. PubMed ID: 19482474
    [No Abstract]   [Full Text] [Related]  

  • 7. Can outcomes in Duchenne muscular dystrophy be improved by public reporting of data?
    Peay HL; Scully MA; Cwik VA; Ciafaloni E; Griggs RC
    Neurology; 2013 Nov; 81(20):1802. PubMed ID: 24218315
    [No Abstract]   [Full Text] [Related]  

  • 8. 226
    Aartsma-Rus A; Ferlini A; McNally EM; Spitali P; Sweeney HL;
    Neuromuscul Disord; 2018 Jan; 28(1):77-86. PubMed ID: 29203356
    [No Abstract]   [Full Text] [Related]  

  • 9. Duchenne muscular dystrophy.
    Biggar WD
    Pediatr Rev; 2006 Mar; 27(3):83-8. PubMed ID: 16510548
    [No Abstract]   [Full Text] [Related]  

  • 10. An Introduction to the Duchenne Muscular Dystrophy Care Considerations.
    Ward LM; Birnkrant DJ
    Pediatrics; 2018 Oct; 142(Suppl 2):S1-S4. PubMed ID: 30275244
    [No Abstract]   [Full Text] [Related]  

  • 11. New Developments in Diagnosis, Treatment, and Management of Duchenne Muscular Dystrophy.
    Gieron-Korthals M; Fernandez R
    Adv Pediatr; 2020 Aug; 67():183-196. PubMed ID: 32591061
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk Factors for Cerebral Infarction in Duchenne Muscular Dystrophy: Review With our 2 Cases.
    Nozaki F; Kusunoki T; Kumada T; Shibata M; Fujii T
    J Stroke Cerebrovasc Dis; 2019 Sep; 28(9):2453-2458. PubMed ID: 31311695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Missed opportunities for duchenne muscular dystrophy.
    Kaufmann P
    J Pediatr; 2009 Sep; 155(3):309-10. PubMed ID: 19732575
    [No Abstract]   [Full Text] [Related]  

  • 14. Duchenne muscular dystrophy: issues in expanding newborn screening.
    Kemper AR; Wake MA
    Curr Opin Pediatr; 2007 Dec; 19(6):700-4. PubMed ID: 18025940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technology insight: therapy for Duchenne muscular dystrophy-an opportunity for personalized medicine?
    Lim LE; Rando TA
    Nat Clin Pract Neurol; 2008 Mar; 4(3):149-58. PubMed ID: 18268530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of Duchenne muscular dystrophy (DMD) for the pediatricians in the community.
    Verma S; Anziska Y; Cracco J
    Clin Pediatr (Phila); 2010 Nov; 49(11):1011-7. PubMed ID: 20724320
    [No Abstract]   [Full Text] [Related]  

  • 17. Current management of Duchenne muscular dystrophy in the Middle East: expert report.
    Jumah MA; Muhaizea MA; Rumayyan AA; Saman AA; Shehri AA; Cupler E; Jan M; Madani AA; Fathalla W; Kashyape P; Kodavooru G; Thihli KA; Bastaki L; Megarbane A; Skrypnyk C; Zamani G; Tuffery-Giraud S; Urtizberea A; Ortez González CI
    Neurodegener Dis Manag; 2019 Jun; 9(3):123-133. PubMed ID: 31166138
    [No Abstract]   [Full Text] [Related]  

  • 18. [Frontline studies on Duchenne muscular dystrophy treatment].
    Matsuo M
    No To Hattatsu; 2009 Mar; 41(2):92-5. PubMed ID: 19517771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical studies for gene therapy of Duchenne muscular dystrophy.
    Odom GL; Banks GB; Schultz BR; Gregorevic P; Chamberlain JS
    J Child Neurol; 2010 Sep; 25(9):1149-57. PubMed ID: 20498332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of genetic diagnosis for Duchenne muscular dystrophy.
    Aartsma-Rus A; Ginjaar IB; Bushby K
    J Med Genet; 2016 Mar; 53(3):145-51. PubMed ID: 26754139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.